From: Extravasation of [177Lu]Lu-DOTATOC: case report and discussion
First treatment (extravasation) | Second treatment (i.v. injection) | ||
Activity (GBq) | 7.5 | 7.6 | |
Right kidney | Absorbed dose (Gy) | 3.3 | 2.9 |
Specific dose (Gy/GBq) | 0.45 | 0.37 | |
Effective half-life (days) | 2.0 | 1.9 | |
Left kidney | Absorbed dose (Gy) | 3.1 | 2.7 |
Specific dose (Gy/GBq) | 0.42 | 0.36 | |
Effective half-life (days) | 2.0 | 2.0 | |
Tumor 1 | Absorbed dose (Gy) | 25 | 25 |
Specific dose (Gy/GBq) | 3.3 | 3.3 | |
Effective half-life (days) | 3.7 | 3.4 | |
Tumor 2 | Absorbed dose (Gy) | 16 | 19 |
Specific dose (Gy/GBq) | 2.1 | 2.5 | |
Effective half-life (days) | 3.7 | 3.5 |